Respiratory
Montelukast and Levocetirizine Combination Therapy Evaluated in Asthma and Allergic Rhinitis Patients

A double-blind study assesses the efficacy and safety of a combination therapy of montelukast and levocetirizine in patients with asthma and allergic rhinitis, shedding light on its potential role in managing concurrent respiratory conditions.

January 2023

Additional Approach Demonstrates Effectiveness of
Additional Approach Demonstrates Effectiveness of COVID-19 Vaccines in Reducing Pneumonia

Assessment of pneumonia chest CT scans provides an additional approach to demonstrating the effectiveness of different COVID-19 vaccines in reducing the risk of severe respiratory complications, complementing existing clinical trial data.

January 2023

Extensive adrenal suppression by inhaled corticosteroids in asthma

Routine cortisol monitoring may be warranted for patients with asthma using inhaled corticosteroid therapy.

January 2023

Neuropsychiatric Sequelae of Severe COVID-19 Compa
Neuropsychiatric Sequelae of Severe COVID-19 Compared with Other Respiratory Infections

Risks of neuropsychiatric illness or initiation of related medications are similar for severe COVID-19 and non-COVID severe respiratory infections, underscoring the broader impact of severe respiratory illnesses on mental health outcomes.

December 2022

Thunderstorm Asthma Confirmed as a Real Phenomenon

Thunderstorm asthma is confirmed as a real phenomenon, characterized by excessive risks of exacerbations in susceptible individuals during thunderstorm events, prompting increased awareness and preventive measures in vulnerable populations.

December 2022

Clinical Characteristics and Management of Human M
Clinical Characteristics and Management of Human Monkeypox Examined

Human monkeypox cases challenge current prevention guidance due to prolonged shedding of viral DNA from the upper respiratory tract after resolution of skin lesions, emphasizing the need for updated management strategies and preventive measures.

December 2022

Respiratory Syncytial Virus: Over 100,000 Deaths W
Respiratory Syncytial Virus: Over 100,000 Deaths Worldwide

Respiratory Syncytial Virus (RSV) contributes to over 100,000 deaths globally, with nearly half of these deaths occurring in children under six months of age, highlighting the need for effective prevention and management strategies, particularly in vulnerable populations.

December 2022

Awake Prone Positioning's Effect on Endotracheal Intubation Examined in Clinical Trial

A randomized clinical trial investigates the effect of awake prone positioning on the need for endotracheal intubation, offering insights into its potential role as a non-invasive intervention for respiratory support in critically ill patients.

December 2022

Persistent Health Issues Six Months After COVID-19
Persistent Health Issues Six Months After COVID-19 Hospitalization Extend Beyond Pulmonary Recovery

Individuals hospitalized for COVID-19 continue to experience persistent health problems beyond pulmonary recovery, emphasizing the need for comprehensive post-acute care strategies to address multi-system sequelae and long-term morbidity associated with COVID-19.

December 2022

Exacerbation-Prone Phenotypes Identified in Asthma and COPD

Five distinct exacerbation-prone phenotypes are identified in both asthma and chronic obstructive pulmonary disease (COPD), offering insights into personalized risk stratification and targeted management approaches for exacerbation prevention.

November 2022